S&P 500

5.582,05

0,32%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Provention Bio Inc (PRVB)
Provention Bio Inc (PRVB) Notícias

PRVB

Provention Bio (PRVB)

Provention Bio Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:PRVB

1 2 3 4 5 6 7 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
08/05/2023	17:18	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:PRVB	Provention Bio Inc
01/05/2023	07:20	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:PRVB	Provention Bio Inc
28/04/2023	17:21	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:PRVB	Provention Bio Inc
27/04/2023	19:09	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PRVB	Provention Bio Inc
27/04/2023	18:01	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:PRVB	Provention Bio Inc
27/04/2023	17:49	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:PRVB	Provention Bio Inc
27/04/2023	10:18	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PRVB	Provention Bio Inc
27/04/2023	09:37	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:PRVB	Provention Bio Inc
19/04/2023	18:11	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:PRVB	Provention Bio Inc
29/03/2023	18:10	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:PRVB	Provention Bio Inc
24/03/2023	08:53	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:PRVB	Provention Bio Inc
24/03/2023	08:11	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	NASDAQ:PRVB	Provention Bio Inc
24/03/2023	07:05	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:PRVB	Provention Bio Inc
17/03/2023	17:17	Edgar (US Regulatory)	Written Communication Relating to an Issuer or Third Party (sc To-c)	NASDAQ:PRVB	Provention Bio Inc
13/03/2023	17:39	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:PRVB	Provention Bio Inc
13/03/2023	08:00	PR Newswire (US)	Provention Bio Cancels Fourth Quarter and Full Year 2022 Earnings Release and Conference Call	NASDAQ:PRVB	Provention Bio Inc
03/03/2023	18:05	PR Newswire (US)	Provention Bio Announces the Grant of Inducement Awards	NASDAQ:PRVB	Provention Bio Inc
23/02/2023	10:30	PR Newswire (US)	Provention Bio to Report Fourth Quarter and Full Year 2022 Financial Results on March 16, 2023	NASDAQ:PRVB	Provention Bio Inc
13/02/2023	09:30	PR Newswire (US)	Provention Bio Announces Completion of $35 Million Equity Investment from Sanofi US	NASDAQ:PRVB	Provention Bio Inc
08/02/2023	09:30	PR Newswire (US)	Provention Bio to Present at the SVB Securities Global Biopharma Conference	NASDAQ:PRVB	Provention Bio Inc
02/02/2023	18:01	PR Newswire (US)	Provention Bio Announces Closing of Second Tranche with Hercules Capital to Support U.S. Commercial Launch of TZIELD®	NASDAQ:PRVB	Provention Bio Inc
05/01/2023	18:01	PR Newswire (US)	Provention Bio Announces Appointment of Rita Jain, M.D., to Board of Directors	NASDAQ:PRVB	Provention Bio Inc
21/11/2022	09:35	TipRanks	Provention Bio (PRVB) Receives a Buy from SVB Securities	NASDAQ:PRVB	Provention Bio Inc
21/11/2022	01:15	TipRanks	SVB Securities Remains a Buy on Provention Bio (PRVB)	NASDAQ:PRVB	Provention Bio Inc
18/11/2022	19:55	TipRanks	Chardan Capital Sticks to Their Buy Rating for Provention Bio (PRVB)	NASDAQ:PRVB	Provention Bio Inc
18/11/2022	07:09	TipRanks	Provention Bio (NASDAQ:PRVB) Stock Spikes as Diabetes Drug Gets FDA’s Nod	NASDAQ:PRVB	Provention Bio Inc
17/11/2022	20:57	Dow Jones News	Provention Bio Up 8% on Diabetes Drug Approval	NASDAQ:PRVB	Provention Bio Inc
17/11/2022	20:39	Dow Jones News	Provention Bio Gets FDA OK for Diabetes Drug	NASDAQ:PRVB	Provention Bio Inc
17/11/2022	19:45	PR Newswire (US)	TZIELD™ (teplizumab-mzwv) approved by FDA as the first and only treatment indicated to delay the onset of Stage 3 type 1 diabetes (T1D) in adult and pediatric patients aged 8 years and older with Stage 2 T1D	NASDAQ:PRVB	Provention Bio Inc
07/11/2022	00:35	TipRanks	Provention Bio (PRVB) Gets a Buy from SVB Securities	NASDAQ:PRVB	Provention Bio Inc